MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Ordering Rules
20 questions · exam conditions
0:00
Ordering RulesQuestion 1 of 20

Which DEA form (or electronic equivalent) must a pharmacy use to order Schedule II controlled substances from a distributor?

DEA Form 224
DEA Form 41
DEA Form 106
DEA Form 222 or CSOS
← Back to quizzes

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Ordering Rules

Practice Ordering Rules in MPJE: Multistate Pharmacy Jurisprudence Examination with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Ordering Rules, giving you a quick way to practice the rules, question types, and explanations that matter most for MPJE: Multistate Pharmacy Jurisprudence Examination.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Which DEA form (or electronic equivalent) must a pharmacy use to order Schedule II controlled substances from a distributor?

  1. DEA Form 224
  2. DEA Form 41
  3. DEA Form 106
  4. DEA Form 222 or CSOS (correct answer)
Explanation: Schedule I and II controlled substances must be ordered using DEA Form 222 (a triplicate paper order form) or through the Controlled Substances Ordering System (CSOS), which is the electronic equivalent authorized under 21 CFR Part 1305. DEA Form 224 is for pharmacy registration; DEA Form 41 is for destruction; DEA Form 106 is for reporting theft or significant loss.

Question 2

A wholesale distributor suspects a pharmacy is placing unusually large and frequent orders for Schedule II opioids compared to similarly-sized pharmacies. What federal obligation applies to the distributor?

  1. The distributor must notify the pharmacy's state board of pharmacy before filling the order
  2. The distributor must require the pharmacy to submit a patient count report before fulfilling the order
  3. The distributor must identify, investigate, and report suspicious orders to the DEA before shipping (correct answer)
  4. The distributor may fill the order as long as a valid DEA Form 222 is presented
Explanation: DEA regulations require distributors (manufacturers and wholesale distributors) to maintain a Suspicious Order Monitoring (SOM) program. When a suspicious order is identified - based on unusual size, frequency, or pattern - the distributor must report it to the DEA before fulfilling the order and may decline to ship. The existence of a valid DEA Form 222 does not override the SOM obligation. Notification goes to the DEA, not the state board.

Question 3

A state law requires pharmacies to report all Schedule II purchases to the state's prescription drug monitoring program (PDMP). A pharmacy argues that DEA Form 222 compliance is sufficient and the state reporting is redundant. Which analysis BEST addresses this argument?

  1. The pharmacy is correct; DEA Form 222 compliance preempts all state ordering reporting requirements
  2. The state reporting requirement is invalid because controlled substances are exclusively regulated by federal law
  3. State reporting requirements apply only to dispensing, not to ordering
  4. States can impose additional reporting requirements for Schedule II orders if not conflicting with federal law. (correct answer)
Explanation: The Supremacy Clause allows federal law to preempt state law only when there is a direct conflict or Congress expressly preempts state regulation. DEA ordering requirements do not preempt state law requirements to report purchases to PDMPs. States retain authority to impose additional reporting and monitoring requirements as part of their police powers, even when federal obligations are also met. The pharmacy must comply with both.

Question 4

A pharmacy discovers that a shipment of Schedule II opioids was delivered without a corresponding DEA Form 222 on file. The distributor claims the form was lost in transit. Which analysis BEST describes the pharmacy's obligation?

  1. Accept the shipment and document the receipt; no further action is needed since the distributor is responsible for the form
  2. Return the entire shipment since it cannot be accepted without a Form 222
  3. File a DEA Form 106 for the missing Form 222
  4. Refuse the shipment until a valid DEA Form 222 or CSOS record is obtained for the Schedule II opioids. (correct answer)
Explanation: Every receipt of Schedule II controlled substances must be supported by a DEA Form 222 or CSOS transaction. Accepting and retaining a Schedule II shipment without proper documentation violates DEA regulations and the pharmacy's recordkeeping obligations. The pharmacy bears responsibility for ensuring proper documentation exists, regardless of the distributor's claim. DEA Form 106 is for theft or significant loss, not recordkeeping deficiencies.

Question 5

During a DEA inspection, an agent notes that the pharmacy cannot produce DEA Form 222s for several Schedule II purchases made 18 months ago. The PIC claims the forms were filed but cannot be located. Which analysis BEST describes the pharmacy's compliance status?

  1. No violation exists because the purchases were made more than 1 year ago
  2. Only a minor violation because 18 months is close to the 2-year retention requirement
  3. No violation if the pharmacy can demonstrate the purchases through bank statements
  4. A recordkeeping violation exists due to failure to produce DEA Form 222s for inspection. (correct answer)
Explanation: DEA regulations require that controlled substance records - including DEA Form 222s - be retained for at least 2 years and be readily retrievable upon DEA request. Forms from 18 months ago fall within the required retention window. Inability to produce them during a DEA inspection constitutes a recordkeeping violation regardless of whether the purchases actually occurred. Bank statements do not substitute for DEA-required documentation.

Question 6

A pharmacy wants to use the Controlled Substances Ordering System (CSOS) instead of paper DEA Form 222. What is required to use CSOS?

  1. A separate DEA registration specifically for electronic ordering
  2. A DEA-issued CSOS digital certificate for the registrant authorized to sign orders (correct answer)
  3. FDA approval of the pharmacy's electronic ordering software
  4. Prior written authorization from the state board of pharmacy
Explanation: CSOS requires a DEA-issued digital certificate (PKI certificate) for the registrant or their authorized designee to sign electronic Schedule I and II orders. This certificate provides the authentication equivalent to a handwritten signature on DEA Form 222. No separate DEA registration is needed for CSOS - the existing registration number is used. The FDA and state board do not authorize CSOS participation.

Question 7

A pharmacy orders Schedule III controlled substances from a wholesale distributor. Which of the following is required for this transaction?

  1. A completed DEA Form 222 for each Schedule III order
  2. CSOS electronic ordering for all Schedule III transactions
  3. A DEA Form 41 submitted to the distributor prior to ordering
  4. A standard purchase order or invoice reflecting the pharmacy's DEA registration number (correct answer)
Explanation: Schedule III, IV, and V controlled substances do not require DEA Form 222 or CSOS for ordering. They may be ordered using ordinary business channels - purchase orders or invoices - as long as both the purchaser and seller are DEA-registered. The records of these transactions must be maintained for 2 years. DEA Form 222/CSOS is required only for Schedule I and II ordering.

Question 8

A pharmacist-in-charge (PIC) authorizes a staff pharmacist to sign DEA Form 222 orders. What must the PIC do to delegate this authority?

  1. Execute a DEA Power of Attorney (POA) naming the staff pharmacist as an authorized agent to sign DEA Form 222 (correct answer)
  2. Notify the state board of pharmacy about the delegation in writing
  3. Submit a DEA Form 224 amendment adding the staff pharmacist as a co-registrant
  4. Include a signed letter with each DEA Form 222 order authorizing the staff pharmacist for that order
Explanation: DEA regulations allow a registrant to delegate Schedule II ordering authority to another individual through a formal Power of Attorney (POA). The POA must be signed by the registrant, include the delegate's specimen signature, and be kept on file at the pharmacy. State board notification and DEA registration amendments are not required for POA delegation. Per-order letters do not satisfy DEA requirements.

Question 9

A hospital pharmacy receives a Schedule II controlled substance shipment. When must the pharmacy record receipt of the shipment in its controlled substance records?

  1. Within 72 hours of physical receipt
  2. Upon receipt, typically the same business day. (correct answer)
  3. Within 30 days, consistent with the biennial inventory schedule
  4. Only when the next DEA audit is scheduled
Explanation: DEA regulations require that receipt of Schedule II controlled substances be documented in the pharmacy's controlled substance records promptly upon receipt - generally the same business day. Timely recording is essential for accurate inventory tracking and to maintain accountability. The 72-hour window applies to follow-up written orders for emergency oral Schedule II prescriptions, not to receipt recording. Biennial inventory and audits are separate obligations.

Question 10

A DEA Form 222 is prepared but not used within 60 days. What happens to the unfilled order?

  1. The pharmacy may resubmit it with an updated date
  2. The distributor may fill it after obtaining verbal approval from the DEA
  3. The order is void; the pharmacy must prepare a new DEA Form 222 to place the order (correct answer)
  4. The form remains valid indefinitely as long as both parties remain DEA-registered
Explanation: Under DEA regulations, a DEA Form 222 that has not been filled within 60 days of its execution date becomes void. The pharmacy must prepare a new form to place the order. The void form should be retained on file. Updating the date on a stale form or obtaining verbal DEA approval are not acceptable procedures.

Question 11

A retail pharmacy wants to order a Schedule IV controlled substance from a wholesale distributor. The pharmacy's DEA registration is current. What documentation is required for this order?

  1. A completed DEA Form 222 signed by the pharmacist-in-charge
  2. A purchase order or invoice reflecting both parties' DEA registration numbers (correct answer)
  3. A CSOS electronic order submitted through the DEA portal
  4. A DEA Form 224 amendment identifying the Schedule IV substance to be ordered
Explanation: Schedules III, IV, and V controlled substances may be ordered via ordinary commercial channels, using purchase orders or invoices. Both the purchaser and the supplier must be DEA-registered, and the order records must reflect the DEA registration numbers and be retained for 2 years. DEA Form 222 and CSOS are required only for Schedule I and II ordering. DEA Form 224 is the registration application, not an ordering tool.

Question 12

A pharmacy manager is evaluating whether to switch from paper DEA Form 222 to CSOS for Schedule II ordering. Which factor MOST strongly supports adopting CSOS?

  1. CSOS eliminates the pharmacy's obligation to maintain controlled substance records
  2. CSOS orders are processed faster by the DEA than paper forms, reducing wait times
  3. CSOS reduces paper handling, provides an electronic audit trail, and eliminates risks associated with lost or altered paper forms (correct answer)
  4. CSOS is mandated by state law for all pharmacies with annual Schedule II volume above a threshold
Explanation: CSOS offers operational advantages over paper Form 222: it eliminates risks from lost, stolen, or altered paper forms; provides a secure electronic audit trail; speeds up order processing; and reduces administrative burden. However, CSOS does not eliminate recordkeeping obligations - pharmacies must still maintain records. CSOS is not mandated by state law in the scenario described; it is a DEA-authorized alternative to paper Form 222.

Question 13

A pharmacy uses paper DEA Form 222 to order Schedule II opioids. The pharmacist makes an error on one line of the form. What is the correct procedure?

  1. Void the form and start a new DEA Form 222; do not attempt to correct errors on an executed form (correct answer)
  2. Cross out the error, initial it, and continue using the same form
  3. Submit the form with the error and attach a correction memo to the DEA
  4. Contact the distributor to correct the form on the receiving end
Explanation: DEA Form 222 does not permit erasures or alterations. Any error requires the form to be voided. The pharmacist should write 'VOID' on the spoiled form, retain the copy, and prepare a new form. Crossing out and initialing or attaching correction memos are not acceptable for DEA Form 222. Distributors cannot alter the purchaser's order form.

Question 14

A pharmacy's DEA registration expires and it fails to renew before the expiration date. What is the consequence for controlled substance ordering?

  1. The pharmacy may not order, receive, or dispense controlled substances until the registration is reinstated or renewed (correct answer)
  2. The pharmacy may continue ordering Schedule III-V substances but not Schedule I or II
  3. The pharmacy has a 30-day grace period to continue ordering while the renewal is processed
  4. The pharmacy's existing inventory may be dispensed but no new orders may be placed
Explanation: A lapsed DEA registration suspends all controlled substance activities, including ordering, receiving, and dispensing. There is no grace period once the registration expires unless the renewal application was submitted before expiration (in which case the existing registration may continue while the DEA processes the renewal). Schedule restrictions do not apply - a lapsed registration affects all schedules equally.

Question 15

Under DEA regulations, how long must a pharmacy retain completed DEA Form 222s and associated Schedule II records?

  1. 1 year from the date of the transaction
  2. 2 years from the date of the transaction (correct answer)
  3. 5 years from the date of the transaction
  4. 6 years from the date of the transaction
Explanation: DEA regulations require that all controlled substance records, including DEA Form 222s and Schedule II receiving records, be retained for a minimum of 2 years from the date of the transaction and be readily retrievable for DEA inspection. The 6-year retention requirement applies to DSCSA transaction records under federal drug supply chain law, not DEA controlled substance records.

Question 16

A pharmacy is closing permanently. The PIC needs to return remaining Schedule II controlled substance inventory to the manufacturer. What is required?

  1. The pharmacy may ship Schedule II drugs back to the manufacturer using standard commercial carriers without DEA oversight
  2. The pharmacy must use DEA Form 41 to destroy the inventory in place
  3. The pharmacy must notify the state board of pharmacy within 24 hours and surrender all inventory
  4. The manufacturer must issue a DEA Form 222 to the pharmacy to receive the returned Schedule II drugs (correct answer)
Explanation: A DEA Form 222 must be used when Schedule II drugs are transferred from one DEA registrant to another - including returns to manufacturers. The manufacturer (as the receiving registrant) must issue a DEA Form 222 to the pharmacy to document the transfer. DEA Form 41 is for on-site destruction, not return to a manufacturer. State board notification does not substitute for DEA transfer documentation.

Question 17

A pharmacy auditor discovers that the pharmacy's Schedule II ordering records contain multiple DEA Form 222s with the same serial number. What is the MOST likely compliance concern?

  1. Duplicate serial numbers indicate a potential DEA violation and require immediate investigation. (correct answer)
  2. Duplicate serial numbers are acceptable if they are from different distributors
  3. The DEA assigns duplicate serial numbers to high-volume pharmacies as a standard practice
  4. Duplicate serial numbers only require a correction memo filed with the state board
Explanation: DEA Form 222 serial numbers are unique identifiers; duplicate serial numbers in a pharmacy's records signal a serious problem - either recordkeeping errors, forgery, or controlled substance diversion. This finding requires immediate investigation, corrective action, and potentially a report to the DEA. The DEA does not assign duplicate numbers; duplicate numbers across distributors would still be a red flag requiring resolution.

Question 18

A pharmacy wants to transfer its entire Schedule II inventory to a sister pharmacy during a system-wide renovation. What documentation is required?

  1. A DEA Form 41 filed with the DEA certifying the transfer as a destruction event
  2. A DEA Form 222 issued by the receiving pharmacy to document the Schedule II transfer between DEA registrants (correct answer)
  3. A standard invoice reflecting both pharmacies' names and the quantities transferred
  4. A DEA Form 106 documenting the transfer as a controlled substance loss
Explanation: Any transfer of Schedule II controlled substances between DEA registrants - including sister pharmacies - requires a DEA Form 222 (or CSOS transaction) issued by the receiving registrant. The same rules that govern ordering from a distributor apply to transfers between registrants. DEA Form 41 is for destruction; DEA Form 106 is for theft/significant loss; a standard invoice is insufficient for Schedule II transfers.

Question 19

A hospital pharmacy receives a large Schedule II shipment and the receiving pharmacist is not available. A pharmacy technician accepts delivery. Which statement is most accurate?

  1. Pharmacist must verify Schedule II receipt and documentation, even if a technician physically accepts the delivery. (correct answer)
  2. Technicians may never be present when Schedule II drugs are delivered
  3. Schedule II deliveries must be refused unless a pharmacist is physically present to accept them
  4. Technician acceptance of a Schedule II delivery is equivalent to pharmacist acceptance and satisfies all documentation requirements without any pharmacist review.
Explanation: While DEA regulations and state pharmacy laws vary on the specific tasks technicians may perform during controlled substance delivery acceptance, the pharmacist bears ultimate responsibility for verifying the shipment's accuracy against the DEA Form 222 and completing required receipt documentation in the controlled substance records. A technician may assist with or physically receive the delivery in many settings, but the pharmacist's oversight and accountability for final documentation is a consistent regulatory expectation. A correctly identifies this framework. B is incorrect because technicians may be present and involved in the delivery process in many settings; blanket exclusion is not the universal rule. C is incorrect because DEA regulations do not require a pharmacist to be physically present for every delivery; what is required is pharmacist accountability for accurate receipt documentation. D is incorrect because technician acceptance alone does not satisfy all documentation requirements; pharmacist review and accountability for the DEA Form 222 receipt record is required.

Question 20

A pharmacy is moving to a new location. Can the pharmacy's existing DEA registration be used to order controlled substances for the new location?

  1. No; a new DEA registration is required for the new location before ordering controlled substances. (correct answer)
  2. Yes; the pharmacist's DEA number covers all locations where the pharmacist practices
  3. Yes; as long as the state pharmacy license covers the new location, the DEA registration automatically transfers
  4. Yes; the pharmacy may use the old registration for up to 6 months at the new location
Explanation: DEA registration is tied to a specific registered location. Moving to a new address requires either updating the existing registration to reflect the new address before moving or obtaining a new registration. Ordering or handling controlled substances at an unregistered address violates DEA regulations. State pharmacy license coverage does not automatically transfer or extend DEA registration. There is no 6-month grace period for address changes.